Study of Adherence to Colonoscopy in Women

NCT ID: NCT00883545

Last Updated: 2013-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

625 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether women who are offered screening colonoscopy will be more likely to schedule and complete this procedure if they are given the option of a woman endoscopist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Colorectal cancer (CRC) is the third leading cause of cancer death in women. Although there are a variety of options for colon cancer screening, colonoscopy is thought to be the best modality for women. Despite recommendations by multiple societies, adherence to CRC screening among women is suboptimal. One possible barrier to adherence may be the gender of the endoscopist. Recent studies have shown that a large proportion of surveyed women would prefer a woman endoscopist. These studies suggest that having the option of a woman endoscopist would increase adherence to colonoscopy; however, there is no published literature that addresses this question.

Hypothesis

Women who are offered screening colonoscopy will be more likely to schedule and complete this procedure if they are given the option of a woman endoscopist.

Specific Aims

Primary

* Determine whether the option of a woman endoscopist is associated with increased woman patient adherence to screening colonoscopy.
* Assess the proportion of women who request a woman endoscopist when this option is made available to them.

Secondary

\* Identify socio-demographic predictors of (a) completing a screening colonoscopy and (b) requesting a woman endoscopist (e.g. race/ethnicity, age, health insurance, marital status).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Woman endoscopist

Group Type EXPERIMENTAL

Woman endoscopist

Intervention Type OTHER

This group will receive an invitation to schedule a screening colonoscopy with a woman endoscopist.

Usual care

Group Type ACTIVE_COMPARATOR

Usual care

Intervention Type OTHER

This group will receive an invitation to schedule a screening colonoscopy with any available endoscopist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Woman endoscopist

This group will receive an invitation to schedule a screening colonoscopy with a woman endoscopist.

Intervention Type OTHER

Usual care

This group will receive an invitation to schedule a screening colonoscopy with any available endoscopist.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female gender
* Age between 50 and 70
* Receiving primary care at a University Medicine clinic

Exclusion Criteria

* No visit to a University Medicine clinic in 18 months or more
* Deceased
* Pregnant
* Terminal or cancer diagnosis
* No longer receiving primary care at a University Medicine clinic
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas D Denberg, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado Denver Health Sciences Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Colorado Denver Health Sciences Center

Aurora, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-1045

Identifier Type: -

Identifier Source: org_study_id

NCT00903097

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.